Catalent held a ground breaking ceremony at its Bloomington, IN site to mark the start of construction on a $112 million drug product manufacturing facility, which will increase fill/finish capacity in Bloomington by 79,000 square feet. The facility will house a high-speed vial line, utilizing both ready-to-use components and bulk filling; a high-speed flexible syringe/cartridge line; a fully automated vial inspection machine; and all associated services and support areas. Catalent Biologics pla...